Glucotrack (GCTK) Amortization of Deferred Charges (2010 - 2025)

Glucotrack (GCTK) recorded quarterly Amortization of Deferred Charges of $177000.0 in Q4 2025, up 470.97% on a QoQ basis from $31000.0 in Q3 2025, and down 40.6% year-over-year from $298000.0 in Q4 2024.

Glucotrack (GCTK) Amortization of Deferred Charges (2010 - 2025) Analysis & Trends

Glucotrack has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting $177000.0 for Q4 2025.

  • Quarterly Amortization of Deferred Charges fell 40.6% year-over-year to $177000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $213000.0 (changed N/A YoY) and the FY2025 annual result came in at $182000.0, down 71.02% from the prior year.
  • Amortization of Deferred Charges rose to $177000.0 in Q4 2025, from $31000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $298000.0 in Q4 2024 and troughed at $2000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Glucotrack 4.26 -7.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 177,000.00
Dec 31, 2025 177,000.00
Sep 30, 2025 31,000.00
Sep 30, 2025 31,000.00
Jun 30, 2025 2,000.00
Jun 30, 2025 2,000.00
Mar 31, 2025 3,000.00
Mar 31, 2025 3,000.00
Dec 31, 2024 298,000.00
Dec 31, 2024 298,000.00
Dec 31, 2010 269,475.00
Dec 31, 2010 269,475.00